RAIN News ; Rain Oncology to be acquired by Pathos AI for $ in cash per share · Thu, Dec. 14, ; Rain Oncology GAAP EPS of -$ beats by $ · Thu, Nov. Stock Information. Analyst Coverage · Stock Quote & Chart · Historical Price Lookup · Investment Calculator. Financials & SEC FILINGS. Sec Filings · Quarterly. Rain Oncology Inc. is a late-stage precision oncology company. The Company is focused on developing therapies that target oncogenic drivers to genetically. Stock price history for Rain Therapeutics (RAIN). Highest end of day price: $ USD on Lowest end of day price: $ USD on Stock. Insider Trading & Ownership - Rain Therapeutics Inc. (RAIN) ; pm. Buy, Rain Oncology Inc. RAIN, TANG KEVIN C · 10% Owner, $, , $
Check if RAIN Stock has a Buy or Sell Evaluation. RAIN Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Rain Therapeutics Inc. News. Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its. RAIN Rain Therapeutics Inc. $ $ (%). Today. Watchers, Wk Low, $ Wk High, $ Market Cap, $M. Volume, M. Create and manipulate a RAIN ONCOLOGY (NSQ:RAIN) stock price chart, with moving average, RSI & MACD overlays. Add your portfolio transactions. According to Rain Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 36,, At the end of. stock of Rain Therapeutics Inc. We are offering 7,, shares of our common stock. Prior to this offering, there has been no public market for our common. According to 11 analysts, the average rating for RAIN stock is "Buy." The month stock price forecast is $, which is an increase of % from the. Use our AI bot to analyze the LIFE SCIENCES sector PHARMACEUTICAL PREPARATIONS industry stock and make informed investment decisions. Rain Therapeutics Inc. Stock Price Statistics · Beta (5Y), ; Short Selling Information · Short Interest, , ; Income Statement. Revenue, n/a ; Balance Sheet · Cash & Cash. Rain Therapeutics Inc. (RAIN) Q4 Earnings Call Transcript. RAIN earnings call for the period ending December 31, Motley Fool Transcribing. News for Rain Therapeutics Inc Registered Shs Why Is Greenhill (GHL) Stock Up % Today? Why Is RAIN Stock Down 87% Today? TipRanks d.
Rain Oncology (RAIN) raised $ million in an initial public offering (IPO) on Friday, April 23rd The company issued 7,, shares at a price of. What Is the Rain Therapeutics Inc Stock Price Today? The Rain Therapeutics Inc stock price today is What Is the Stock Symbol for Rain Therapeutics Inc? The latest Rain Therapeutics stock prices, stock quotes, news, and RAIN history to help you invest and trade smarter. The purpose of this Rain Therapeutics Inc. Employee Stock Purchase Plan (the “Plan”) is to provide employees of the Company and its Designated. RAIN | Complete Rain City Resources Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Rain Oncology's valuation in April was $M. Rain Oncology's latest post-money valuation is from April Sign up for a free demo to see Rain. Rain Oncology researches, develops and translates innovative targeted cancer therapies to patients. Rain Oncology to be acquired by Pathos AI for $ in cash per share · Thu, Dec. 14, Comment ; Rain Oncology GAAP EPS of -$ beats by $ · Thu, Nov. Performance ; Rain Therapeutics (RAIN). , , , ; BSE Sensex · , , ,
Weekly Report: what happened at RAIN last week ()?. Weekly Report · 01/29 Rain Therapeutics Revamps Governance. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Rain Oncology Inc. (NasdaqGS: RAIN) reports financial results for Q2 , with a quarter-end cash position of $ million. The company is evaluating. Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Rain City Resources Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range - 52 Wk Range.
This *PERFECT PULLBACK* Could Make Us a FORTUNE Tomorrow!
Company analysis RAIN Rain Therapeutics Inc. Common Stock includes quotes, information about dividends and payment history, reporting of companies for
What Is A Typical Plumbers Hourly Rate | What Does A Good Onboarding Process Look Like